“NANOPARTICLE-BASED TARGETED DRUG DELIVERY FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS”, JMHSR, vol. 2, no. 2, Jun. 2025, doi: 10.62019/762rmz59.